Skip to main content

Table 1 HER2 positive incidence

From: Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Country

Incidence

Sources

Congo

Not found

 

Ethiopia

23%

[31]

Guinea

Not found

 

Kenya

26%

[33]

Namibia

Not found

 

Nigeria

26%

[34]

Rwanda

26.3%

[35]

Uganda

22%

[36]

Zambia

Not found

 

Zimbabwe

Not found

 

South Africa

22.50%

[37]

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us